分支链氨基酸代谢在心力衰竭中的代谢
Chenshan Gao1, Lei Hou1,2
1Collaborative Innovation Centre of Regenerative Medicine and Medical BioResource Development and Application Co-Constructed by the Province and Ministry, Guangxi Medical University, Nanning, China.
Frontiers in nutrition
|December 11, 2023
概括
支链氨基酸 (BCAA) 代谢中断与心力衰竭的进展有关. 调节BCAA代谢为评估心脏代谢风险提供了潜在的治疗策略和生物标志物.
科学领域:
- 心血管医学 心血管医学
- 代谢研究研究 代谢研究
- 生物化学 生物化学
背景情况:
- 心力衰竭是一种严重的心血管疾病阶段,死亡率高,治疗方法有限.
- 研究代谢途径,包括碳水化合物,脂肪酸和氨基酸,对于改善心血管疾病预后至关重要.
- 分链氨基酸 (BCAA) 对葡萄糖调节,蛋白质合成和胰岛素敏感性至关重要,但它们的代谢中断与高血压,肥胖和动脉样硬化有关.
研究的目的:
- 探索复杂的代谢途径,将破坏的BCAA代谢与心力衰竭的进展联系起来.
- 讨论针对BCAA代谢治疗心力衰竭治疗的治疗策略.
- 评估BCAA对心脏功能障碍的影响及其作为心脏代谢风险生物标志物的潜力.
主要方法:
- 审查目前关于心血管疾病中BCAA代谢的研究.
- 分析BCAA,心脏功能障碍和心力衰竭进展之间的关系.
- 探索旨在调节BCAA代谢的治疗干预措施.
主要成果:
- 破坏BCAA代谢与心力衰竭的进展有关.
- BCAA及其代谢物显示出作为心脏代谢风险生物标志物的潜力.
- 调节BCAA代谢为心力衰竭提供了一个有希望的治疗途径.
结论:
- 在心力衰竭和整体心血管健康中,BCAA发挥着多方面的作用.
- 准BCAA代谢可能为心力衰竭提供新的治疗策略.
- 需要进一步的研究,以充分阐明BCAA调节在心血管医学中的治疗潜力.
相关概念视频
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
436
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
436
01:17Pathophysiology of Heart Failure
1.6K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.6K
01:22Heart Failure Drugs: β-Blockers
341
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
341
01:26Heart Failure Drugs: Inotropic Agents
594
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
594
01:22Heart Failure Drugs: Diuretics
395
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
395
01:26Imbalances in Cardiac Output
1.4K
The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
1.4K